Newell Brands Inc.
5.36USD
-0.3700 (-6.46%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on NWL.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 9.5B | 8.1B | 7.6B | 7.2B | 7.3B | 7.4B |
| Q1 | 2.4B | 1.8B | 1.7B | 1.6B | 1.5B | — |
| Q2 | 2.5B | 2.2B | 2.0B | 1.9B | 2.0B | — |
| Q3 | 2.3B | 2.0B | 1.9B | 1.8B | 1.9B | — |
| Q4 | 2.3B | 2.1B* | 1.9B* | 1.9B* | 1.9B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | .470 | -.940 | -.520 | -.680 | .760 | .687 |
| Q1 | .540 | -.250 | -.020 | -.090 | -.080 | — |
| Q2 | .480 | .040 | .110 | .110 | .250 | — |
| Q3 | .050 | -.530 | -.480 | .050 | .197 | — |
| Q4 | -.600 |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| -.208* |
| -.130* |
| -.753* |
| .191 |
| — |
Debt level and coverage